Who Hims & Hers buys from and sells to
Cash-pay telehealth platform selling subscriptions for weight loss, hair, sexual and mental health treatments.
Part of GLP-1 and Specialty Pharmaceuticals spending
Buys from 4
- Novo NordiskNVOWegovy and Ozempic offered on the platform since March 2026
- Eli LillyLLYZepbound and Foundayo dispensed through LillyDirect since Apr 2026
- MedisourceRx503B outsourcing-facility compounded drugs
- API and generic drug makersingredients for its own pharmacies and peptide facility
Sells to 1
- Cash-pay subscribersmonthly memberships bundling consults and medication
Where the chain could break
- Branded GLP-1 supply depends on Novo and Lilly agreements that have collapsed before
- Compounded drugs rest on FDA 503A/503B rules that can shut a product line overnight
Competes with
- Rothe largest private telehealth rival in GLP-1s
- AmazonAMZNOne Medical and Amazon Pharmacy
- Eli LillyLLYLillyDirect sells the same drugs direct to patients
Mapped by hand from filings and company reporting, as of October 2026. It shows the relationships that matter most, not every contract: most are never disclosed, and agreements change.